Author Page for Gilles Salles

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Polatuzumab Vedotin in Combination with Immunochemotherapy in Patients with Previously Untreated DLBCL: A Phase 1b/2 Study

Number of pages: 32 Posted: 22 Nov 2018

Herve Tilly, Franck Morschhauser, Nancy L. Bartlett, Amitkumar Mehta, Gilles Salles, Corinne Haioun, Javier Munoz, Andy Chen, Kathryn Kolibaba, Dan Lu, Mark Yan, Elicia Penuel, Jamie Hirata, Calvin Lee and Jeff P. Sharman

University of Rouen - Department of Haematology, University Hospital of Lille, Washington University in St. Louis, University of Alabama at Birmingham, University of Claude Bernard Lyon 1, University Hospital of Henri-Mondor, APHP, University of Texas at Houston - MD Anderson Cancer Center, Oregon Health and Science University, US Oncology Research, Genentech, Inc. - San Francisco, Roche, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco, Genentech, Inc. - San Francisco and US Oncology Research

Downloads 81 (796,622)

Gilles Salles

University of Claude Bernard Lyon 1

1

81

0

Scholarly Papers (1)

Polatuzumab Vedotin in Combination with Immunochemotherapy in Patients with Previously Untreated DLBCL: A Phase 1b/2 Study

Abstract: